English | Español
Patient Daily | Feb 6, 2026

GSK focuses on complications from obesity rather than GLP-1 drugs
Patient Daily | Feb 6, 2026

Eli Lilly sees opportunity as Novo Nordisk's oral Wegovy expands obesity drug market
Patient Daily | Feb 6, 2026

Congressman questions transparency of FDA's priority voucher program
Patient Daily | Feb 6, 2026

Eli Lilly expands tirzepatide trials into immunology with combination therapies
Patient Daily | Feb 6, 2026

AbbVie stresses growth beyond immunology as Skyrizi and Rinvoq lead 2025 sales
Patient Daily | Feb 6, 2026

Rare disease drug development sees growth amid regulatory changes
Patient Daily | Feb 6, 2026

Novo Nordisk focuses on Wegovy pill launch amid rising competition and declining sales outlook
Patient Daily | Feb 6, 2026

Penn Medicine workshop uses writing as therapy for cancer patients

Trending
+ Pharmaceuticals
Patient Daily | Mar 4, 2026

Gene therapies for sickle cell disease face slow uptake despite early promise
Andrea Gelzer, MD | Feb 28, 2026

OPINION: How your prescriptions work — and how to make them more affordable
+ Pharmaceuticals
Patient Daily | Feb 27, 2026

FARE releases national report detailing prevalence and impact of food allergies
+ Regulatory
A. B. Abbott | Mar 4, 2026

Rep. Pappas: Proposed federal student loan policy ‘will make it harder for nursing students to access the loans they need’